Next-generation IHC: identifying TP53 mutation origin in a bone marrow with concurrent CLL and AML - PubMed
3 days ago
- #TP53 mutation
- #IHC
- #bone marrow
- New immunohistochemistry technique identifies TP53 mutation origin in bone marrow with concurrent chronic lymphocytic leukemia and acute myeloid leukemia.
- Published with PMID: 42133324 and DOI: 10.1182/blood.2025032949.
- Focuses on next-generation immunohistochemistry (IHC) methodology.
- Provides access to full text sources, research materials, and other miscellaneous resources.